stoxline Quote Chart Rank Option Currency Glossary
BioSig Technologies, Inc. (BSGM)
0.4  0 (0%)    07-17 15:38
Open: 0.4
High: 0.437
Volume: 3,867
Pre. Close: 0.4
Low: 0.4
Market Cap: 6(M)
Technical analysis
2024-07-17 5:26:01 PM
Short term     
Mid term     
Targets 6-month :  1.24 1-year :  1.86
Resists First :  1.06 Second :  1.59
Pivot price 0.38
Supports First :  0.2 Second :  0.16
MAs MA(5) :  0.41 MA(20) :  0.37
MA(100) :  1 MA(250) :  3.06
MACD MACD :  -0.2 Signal :  -0.3
%K %D K(14,3) :  78.3 D(3) :  87
RSI RSI(14): 35.1
52-week High :  15.5 Low :  0.2
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ BSGM ] has closed below upper band by 36.7%. Bollinger Bands are 89.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.44 - 0.44 0.44 - 0.44
Low: 0.4 - 0.4 0.4 - 0.4
Close: 0.4 - 0.4 0.4 - 0.4
Company Description

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Headline News

Thu, 30 May 2024
BioSig Technologies slumps 18% on $3M equity sale (NASDAQ:BSGM) - Seeking Alpha

Thu, 30 May 2024
Why BioSig Technologies (BSGM) Shares Are Falling - Benzinga

Fri, 03 May 2024
BioSig Technologies Announces Key Leadership Appointment - TipRanks

Fri, 03 May 2024
BioSig Technologies, Inc. Announces New Appointments to its - GlobeNewswire

Tue, 30 Apr 2024
BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately - GlobeNewswire

Thu, 04 Apr 2024
BioSig Engages Consulting Firm for Business Model Strategies - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Devices
Shares Out 0 (M)
Shares Float 15 (M)
Held by Insiders 1.075e+007 (%)
Held by Institutions 0 (%)
Shares Short 962 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -2.395e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -22 %
Return on Assets (ttm) 742.8 %
Return on Equity (ttm) -447.8 %
Qtrly Rev. Growth 27000 %
Gross Profit (p.s.) 276.92
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth -3.2 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -13 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow -0.67
Stock Dividends
Dividend 0
Forward Dividend 461700
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android